Fundraising Fox
/Companies
Sign in

Apogee Therapeutics

NASDAQ: APGE

Founded 2022 · 340 employees on LinkedIn · 6 known investors

Find your way into Apogee Therapeutics

1,032 people in our graph share verified history with the Apogee Therapeutics team — schools, employers, funds. One of them is your warm intro.

Marianne Wuunlockedknows Michael Henderson · together at GE Ventures (overlapped)
×10knows the team · via GE Ventures
knows the team · via Kaiser Permanente Strategic Services

Apogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.

BiotechHealthtechMedical Devices

Founders & leadership

MHMichael Henderson
Michael HendersonChief Executive Officer at Apogee TherapeuticsMichael Henderson holds an M.D. from Stanford University and a B.A. from Harvard University. He is CEO of Apogee Therapeutics, a biotechnology company developing engineered antibody therapies for inflammatory and immune diseases.

Investors · 6

RA Capitallisted by RA CapitalBoston

How we know: RA Capital's portfolio page · the S-1 prospectus · Not right? Tell us

Blackstone Life SciencesreportedNew York · $20M – $60M

How we know: funding news · Not right? Tell us

Perceptive Xontogeny VenturereportedNew York

How we know: the S-1 prospectus · Not right? Tell us

RTW Investments L.P.reportedNew York

How we know: the S-1 prospectus · funding news · Not right? Tell us

Venrock Healthcare Capital PartnersreportedNew York

How we know: the S-1 prospectus · Not right? Tell us

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

Founder mafia

3 people who came through Apogee Therapeutics went on to found or lead other companies.

Nimish ShahCo-Founder and Board DirectorFounded KorsanaAndrew GottesdienerCo-Founder and Board MemberFounded KorsanaMichael HendersonChief Executive Officer and DirectorFounded Pellepharm

Competitors · 2

by search overlap
Bioworld76 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Applied Therapeutics75 shared keywordsApplied Therapeutics is a biopharmaceutical company developing novel drugs for rare diseases with high unmet medical need. Its Aldose Reductase Inhibitor franchise is in development across disease areas including Galactosemia and SORD Deficiency.

Companies competing with Apogee Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Apogee Therapeutics Raises $149M in Series B; $169M in Totalfinsmes.com · Dec 2022Apogee Therapeutics Launches with $169 Million to Develop Potentially Best-in-Class Therapies for Immunological and Inflammatory Disordersprnewswire.com · Dec 2022

Frequently asked questions

What does Apogee Therapeutics do?
Apogee Therapeutics develops engineered antibody therapies to treat inflammatory and immune diseases with reduced injection frequency compared to existing treatments.
Who are Apogee Therapeutics's investors?
Apogee Therapeutics's investors include Access Biotechnology, RA Capital, Blackstone Life Sciences, Perceptive Xontogeny Venture, RTW Investments L.P., Venrock Healthcare Capital Partners.